Lytham Partners, a leading investor relations firm, today announced the schedule for its Fall 2024 Investor Conference taking ...
MannKind (MNKD) reported top-level 30-week results from Phase 4 INHALE-3 study, in which additional patients living with type 1 ...
The "Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Nontuberculous Mycobacterial Infections pipeline report offers ...
Check the time stamp on this data. Updated AI-Generated Signals for Mannkind Corporation (MNKD) available here: MNKD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback